New
Leadart Biotechnologies
The AI engine Fit Assessment
BetaLeadArt Biotechnologies develops chemoproteomics and automated drug discovery platforms, directly addressing the pharma tech central requirement for technology solutions in pharmaceutical research and development.
Blurb
Leadart Biotechnologies is a biotechnology company that focuses on automating chemoprotomic drug discovery.
HQ Location
Ningbo (China)
Founded
2017
Employees
11 - 50
Total funding raised
$6.00M
Funding Status
Seed, $6.00M, December 27, 2022
Chemoproteomics and automation dual driver platform.
Expand the target space and accelerate drug discovery